Depot antipsychotic use in New York state hospitals, 1994 to 2009

Psychiatric Services

Volumn 61, Issue 1, 2010, Pages 9-

  Citrome, Leslie ^a,b   Jaffe, Ari ^a,b   Levine, Jerome ^a,b  

^a NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUPHENAZINE; FLUPHENAZINE ENANTHATE; HALOPERIDOL; RISPERIDONE; NEUROLEPTIC AGENT;

DRUG APPROVAL; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG UTILIZATION; ETHNICITY; GROUPS BY AGE; HOSPITAL; HOSPITAL PATIENT; HUMAN; LENGTH OF STAY; PATIENT COMPLIANCE; PRESCRIPTION; PSYCHIATRIC DIAGNOSIS; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SEX DIFFERENCE; SHORT SURVEY; UNITED STATES; ARTICLE; DATA BASE; DELAYED RELEASE FORMULATION; DRUG THERAPY; MENTAL HOSPITAL; STATISTICS;

ANTIPSYCHOTIC AGENTS; DATABASES AS TOPIC; DELAYED-ACTION PREPARATIONS; DRUG THERAPY; HOSPITALS, PSYCHIATRIC; HUMANS; NEW YORK;

EID: 74849092225     PISSN: 10752730     EISSN: 15579700     Source Type: Journal    
DOI: 10.1176/appi.ps.61.1.9     Document Type: Short Survey

References (1)

1. Citrome L, Levine J, Allingham B: Utilization of depot neuroleptic medication in psychiatric inpatients. Psychopharmacology Bulletin 32:321-326, 1996